Results 91 to 100 of about 37,607 (177)

A new era of macrophage-based cell therapy. [PDF]

Exp Mol Med, 2023
Na YR, Kim SW, Seok SH.
europepmc   +1 more source

Not the Last Word: When Physicians Compete, Patients Can Win. [PDF]

Clin Orthop Relat Res
Bernstein J.
europepmc   +1 more source

Paraquat at 63-the story of a controversial herbicide and its regulations: It is time to put people and public health first when regulating paraquat. [PDF]

BMC Public Health
Utyasheva L, Amarasinghe P, Eddleston M.
europepmc   +1 more source

Patent landscape analysis for materials based on fungal mycelium: a guidance report on how to interpret the current patent situation. [PDF]

Fungal Biol Biotechnol
Meyer V, Mengel S.
europepmc   +1 more source

Redefining Counterfeit Medicines and Updating the Legal Framework to Address Falsified Medicines: A Qualitative Policy Review. [PDF]

Acta Med Philipp
Peña IG, Robles YR, Salenga RL, Loquias MM, Capule FR, Bulatao BPI, Casauay JFC.   +6 more
europepmc   +1 more source

The future of AI regulation in drug development: a comparative analysis. [PDF]

J Law Biosci
Lenarczyk G, Minssen T, Price N, Rai A.
europepmc   +1 more source

Can the right to science redress inequitable access to innovative cancer therapy? A case for the justiciability of this 'lesser known' human right. [PDF]

J Law Biosci
Zakout GA.
europepmc   +1 more source

Evolving intellectual property landscape for AI-driven innovations in the biomedical sector: opportunities in stable IP regime for shared success. [PDF]

Front Artif Intell
Poddar A, Rao SR.
europepmc   +1 more source

The FRAND Ceremony and the Engagement of Article 102 TFEU in the Licensing of Standard Essential Patents [PDF]

, 2019
Jeffery Atik
core   +1 more source

Reforming medical career progression: a call for merit-based systems. [PDF]

Front Med (Lausanne)
Bulletti FM, Guido M, Coccia ME, Palagiano A, Giacomucci E, Bulletti C.   +5 more
europepmc   +1 more source